173 related articles for article (PubMed ID: 19011639)
1. Peptidase substrates via global peptide profiling.
Tagore DM; Nolte WM; Neveu JM; Rangel R; Guzman-Rojas L; Pasqualini R; Arap W; Lane WS; Saghatelian A
Nat Chem Biol; 2009 Jan; 5(1):23-5. PubMed ID: 19011639
[TBL] [Abstract][Full Text] [Related]
2. Expanding the dipeptidyl peptidase 4-regulated peptidome via an optimized peptidomics platform.
Tinoco AD; Tagore DM; Saghatelian A
J Am Chem Soc; 2010 Mar; 132(11):3819-30. PubMed ID: 20178363
[TBL] [Abstract][Full Text] [Related]
3. Crystal structure of Porphyromonas gingivalis dipeptidyl peptidase 4 and structure-activity relationships based on inhibitor profiling.
Rea D; Van Elzen R; De Winter H; Van Goethem S; Landuyt B; Luyten W; Schoofs L; Van Der Veken P; Augustyns K; De Meester I; Fülöp V; Lambeir AM
Eur J Med Chem; 2017 Oct; 139():482-491. PubMed ID: 28826083
[TBL] [Abstract][Full Text] [Related]
4. Dipeptidyl Peptidase IV as a Prognostic Marker and Therapeutic Target in Papillary Thyroid Carcinoma.
Lee JJ; Wang TY; Liu CL; Chien MN; Chen MJ; Hsu YC; Leung CH; Cheng SP
J Clin Endocrinol Metab; 2017 Aug; 102(8):2930-2940. PubMed ID: 28575350
[TBL] [Abstract][Full Text] [Related]
5. Role of dipeptidyl peptidase-4 as a potentiator of activin/nodal signaling pathway.
Park DS; Kim K; Jang M; Choi SC
BMB Rep; 2018 Dec; 51(12):636-641. PubMed ID: 30463640
[TBL] [Abstract][Full Text] [Related]
6. Pharmacology, physiology, and mechanisms of action of dipeptidyl peptidase-4 inhibitors.
Mulvihill EE; Drucker DJ
Endocr Rev; 2014 Dec; 35(6):992-1019. PubMed ID: 25216328
[TBL] [Abstract][Full Text] [Related]
7. Mass spectrometry-assisted confirmation of the inability of dipeptidyl peptidase-4 to cleave goldfish peptide YY(1-36) and the lack of anorexigenic effects of peptide YY(3-36) in goldfish (Carassius auratus).
Gonzalez R; Unniappan S
Fish Physiol Biochem; 2016 Jun; 42(3):831-44. PubMed ID: 26676513
[TBL] [Abstract][Full Text] [Related]
8. The pro-fibrotic role of dipeptidyl peptidase 4 in carbon tetrachloride-induced experimental liver injury.
Wang XM; Holz LE; Chowdhury S; Cordoba SP; Evans KA; Gall MG; Vieira de Ribeiro AJ; Zheng YZ; Levy MT; Yu DM; Yao TW; Polak N; Jolly CJ; Bertolino P; McCaughan GW; Gorrell MD
Immunol Cell Biol; 2017 May; 95(5):443-453. PubMed ID: 27899813
[TBL] [Abstract][Full Text] [Related]
9. Dipeptidyl peptidase inhibitor therapy in type 2 diabetes: Control of the incretin axis and regulation of postprandial glucose and lipid metabolism.
Mulvihill EE
Peptides; 2018 Feb; 100():158-164. PubMed ID: 29412815
[TBL] [Abstract][Full Text] [Related]
10. Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system.
Klemann C; Wagner L; Stephan M; von Hörsten S
Clin Exp Immunol; 2016 Jul; 185(1):1-21. PubMed ID: 26919392
[TBL] [Abstract][Full Text] [Related]
11. Dipeptidyl peptidase-4 inhibition: insights from the bench and recent clinical studies.
Zhong J; Kankanala S; Rajagopalan S
Curr Opin Lipidol; 2016 Oct; 27(5):484-92. PubMed ID: 27472408
[TBL] [Abstract][Full Text] [Related]
12. Dipeptidyl Peptidase-4 Regulates Hematopoietic Stem Cell Activation in Response to Chronic Stress.
Zhu E; Hu L; Wu H; Piao L; Zhao G; Inoue A; Kim W; Yu C; Xu W; Bando YK; Li X; Lei Y; Hao CN; Takeshita K; Kim WS; Okumura K; Murohara T; Kuzuya M; Cheng XW
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28710180
[TBL] [Abstract][Full Text] [Related]
13. Emerging Role of Dipeptidyl Peptidase-4 in Autoimmune Disease.
Huang J; Liu X; Wei Y; Li X; Gao S; Dong L; Rao X; Zhong J
Front Immunol; 2022; 13():830863. PubMed ID: 35309368
[TBL] [Abstract][Full Text] [Related]
14. Dipeptidyl peptidase 8 has post-proline dipeptidyl aminopeptidase and prolyl endopeptidase activities.
Park J; Ajami K; Yu DM; Gorrell MD
Adv Exp Med Biol; 2006; 575():93-102. PubMed ID: 16700512
[No Abstract] [Full Text] [Related]
15. An interaction between glucagon-like peptide-1 and adenosine contributes to cardioprotection of a dipeptidyl peptidase 4 inhibitor from myocardial ischemia-reperfusion injury.
Ihara M; Asanuma H; Yamazaki S; Kato H; Asano Y; Shinozaki Y; Mori H; Minamino T; Asakura M; Sugimachi M; Mochizuki N; Kitakaze M
Am J Physiol Heart Circ Physiol; 2015 May; 308(10):H1287-97. PubMed ID: 25747753
[TBL] [Abstract][Full Text] [Related]
16. A time-resolved fluorescence probe for dipeptidyl peptidase 4 and its application in inhibitor screening.
Kawaguchi M; Okabe T; Terai T; Hanaoka K; Kojima H; Minegishi I; Nagano T
Chemistry; 2010 Dec; 16(45):13479-86. PubMed ID: 20938933
[TBL] [Abstract][Full Text] [Related]
17. Boning up on DPP4, DPP4 substrates, and DPP4-adipokine interactions: Logical reasoning and known facts about bone related effects of DPP4 inhibitors.
Glorie L; D'Haese PC; Verhulst A
Bone; 2016 Nov; 92():37-49. PubMed ID: 27535784
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Dipeptidyl Peptidase-4 Impairs Ventricular Function and Promotes Cardiac Fibrosis in High Fat-Fed Diabetic Mice.
Mulvihill EE; Varin EM; Ussher JR; Campbell JE; Bang KW; Abdullah T; Baggio LL; Drucker DJ
Diabetes; 2016 Mar; 65(3):742-54. PubMed ID: 26672095
[TBL] [Abstract][Full Text] [Related]
19. Context-dependent effects of dipeptidyl peptidase 4 inhibitors.
Jackson EK
Curr Opin Nephrol Hypertens; 2017 Mar; 26(2):83-90. PubMed ID: 27898522
[TBL] [Abstract][Full Text] [Related]
20. Dipeptidyl peptidase-4 inhibitor protects against non-alcoholic steatohepatitis in mice by targeting TRAIL receptor-mediated lipoapoptosis via modulating hepatic dipeptidyl peptidase-4 expression.
Lee M; Shin E; Bae J; Cho Y; Lee JY; Lee YH; Lee BW; Kang ES; Cha BS
Sci Rep; 2020 Nov; 10(1):19429. PubMed ID: 33173107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]